医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NuGEN Expands Portfolio of Clinical Sample Solutions

2013年09月24日 PM09:25
このエントリーをはてなブックマークに追加


 

SAN CARLOS, Calif.

NuGEN Technologies, Inc., a market leader in the development of sample preparation solutions for Next Generation Sequencing (NGS) applications, has announced the release of the Ovation Human FFPE RNA-Seq Multiplex System. This kit, optimized for use with human samples, provides an end-to-end solution for strand-specific RNA-Seq library construction using very low input amounts of total RNA derived from formalin-fixed paraffin embedded tissues, and is also suitable for RNA obtained from fresh frozen human tissues or cell lines. The Ovation Human FFPE RNA-Seq Multiplex System complements the recently launched Ovation Human Blood RNA-Seq Multiplex System and together they provide highly effective RNA-Seq sample preparation for the most common sample types handled in clinical research laboratories.

Alan Dance, Vice President of Marketing at NuGEN commented, “From its inception as a company, NuGEN has focused on solutions for precious clinical samples, and is well recognized for innovation and expertise in this area. Not only do clinical samples present a unique set of challenges to scientists, these samples are also the most informative from research and testing perspectives. We are continually striving to apply NuGEN’s unique and innovative technology to enable better analysis of the most challenging samples used in life science research.”

One of the difficulties inherent in FFPE and blood samples respectively is the high abundance of human ribosomal RNA and adult human reticulocyte globin. To address this challenge, NuGEN has developed the novel and proprietary Insert Dependent Adaptor Cleavage (InDA-C) technology. InDA-C provides targeted depletion of unwanted high abundance transcripts for more efficient use of sequencing resources and eliminates the need for additional hybridization based capture steps. This technology is employed in both the Ovation Human FFPE RNA-Seq Multiplex System and the Ovation Human Blood RNA-Seq Multiplex Systems or can be configured as a custom solution to eliminate any transcripts defined by the user prior to sequencing.

About NuGEN

NuGEN Technologies is a San Carlos, CA company focused on innovative sample preparation solutions for RNA and DNA that enable life scientists to do more with less. With reagent solutions that are quick, easy to use, and amenable to automation, NuGEN empowers researchers to prepare genomic samples of any size, from almost any source, regardless of the intended application or technology platform. For more information please visit www.nugeninc.com.

Ovation and NuGEN are registered trademarks of NuGEN Technologies, Inc.

CONTACT

NuGEN Technologies, Inc.
Carol Short, 650-590-3002
media@nugeninc.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc